Recruiting OBSERVATIONAL NCT06006832

A Prospective Cohort Study of Myasthenia Gravis in China

Clinical Characteristics, Prognosis and Biomarkers of Myasthenia Gravis: a Prospective Cohort Study in China

Sponsor: Peking Union Medical College Hospital

Interventions Steroid Drug Withdraw all immunosuppresants

Updated 4 times since 2023 Last updated: Jan 10, 2024 Started: Aug 20, 2023 Primary completion: Sep 30, 2026 Completion: Sep 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Myasthenia Gravis, this trial is actively recruiting participants. The trial is conducted by Peking Union Medical College Hospital and has accumulated 4 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Feb 2024 — Jul 2024 [monthly]

Recruiting
Sep 2023 — Feb 2024 [monthly]

Recruiting

First recorded

Aug 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking Union Medical College Hospital

Data source: Peking Union Medical College Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China